Axonics Inc. (NASDAQ:AXNX) shares fell to a low of $55.0688 before closing at $56.72. Intraday shares traded counted 0.52 million, which was 10.84% higher than its 30-day average trading volume of 581.83K. AXNX’s previous close was $55.98 while the outstanding shares total 39.61M. The stock’s Relative Strength Index (RSI) is 51.66, with weekly volatility at 3.92% and ATR at 2.67. The AXNX stock’s 52-week price range has touched low of $32.15 and a $64.36 high. The stock traded higher over the last trading session, gaining 1.32% on 05/26/21.
Investors have identified the Medical Devices company Axonics Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $2.53 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Axonics Inc. (AXNX) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For AXNX, the company has in raw cash 130.96 million on their books with 22000.0 currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on a decline. In terms of their assets, the company currently has 228.37 million total, with 24.05 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record -0.92 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on AXNX sounds very interesting.
Is the stock of AXNX attractive?
In related news, See Remarks, Dearen Danny L. sold 6,866 shares of the company’s stock in a transaction that recorded on May 21. The sale was performed at an average price of 55.22, for a total value of 379,164. As the sale deal closes, the See Remarks, Dearen Danny L. now sold 43,134 shares of the company’s stock, valued at 2,363,399. Also, Chief Executive Officer, COHEN RAYMOND W sold 32,833 shares of the company’s stock in a deal that was recorded on May 18. The shares were price at an average price of 55.00 per share, with a total market value of 1,805,815. Following this completion of acquisition, the Chief Operating Officer, Sama Rinda now holds 25,000 shares of the company’s stock, valued at 1,333,641. In the last 6 months, insiders have changed their ownership in shares of company stock by 1.00%.
8 out of 9 analysts covering the stock have rated it a Buy, while 0 have maintained a Hold recommendation on Axonics Inc.. 0 analysts has assigned a Sell rating on the AXNX stock. The 12-month mean consensus price target for the company’s shares has been set at $71.33.